ModivCare (MODV) Jefferies Global Healthcare Conference summary
Event summary combining transcript, slides, and related documents.
Jefferies Global Healthcare Conference summary
1 Feb, 2026Transformation and strategic direction
Ongoing transformation since late 2022 aims to capitalize on platform scale and market shift toward home-based and access-focused healthcare.
Strategy centers on delivering lowest cost and best member experience, with significant progress in the last 12-18 months.
Transformation includes building a strong team, implementing new processes, and leveraging technology.
Headwinds from COVID and Medicaid redetermination are largely behind, with focus now on execution.
Market tailwinds support growth as healthcare moves outside clinical settings.
NEMT (Non-Emergency Medical Transport) business outlook
Shifted from a pure capitated model to a shared risk contract structure, reducing margin volatility.
State contracts (~40% of revenue) are stable, with high retention and new wins expected; $600M in state business up for renewal in 2024.
MCO business is growing, with $140M in new annual contract value won last year and $32M last quarter.
Margin improvement driven by automation, digital integration, and cost reduction; targeting 8% EBITDA margin by year-end, normalizing to 9-10% in 2025+.
High single-digit revenue growth expected as business stabilizes post-redetermination.
Execution milestones and cost initiatives
Key metrics to watch: payroll per trip and provider costs, both trending down due to automation.
Technology adoption (app, text, API integration) reduces call volume and enhances member experience.
$30-40M annual cost savings expected, with $60M run rate after full implementation.
Continued focus on ecosystem digitization and process standardization.
Latest events from ModivCare
- Q2 2024 revenue flat at $698.3M, net loss $128.9M, Adjusted EBITDA $45.4M, RPM impairment.MODV
Q2 20242 Feb 2026 - Revenue up 2.2% to $702M, net loss widens, liquidity risks persist, 2024 guidance affirmed.MODV
Q3 202416 Jan 2026 - Q2 2025 loss deepened to $303.7M amid bankruptcy, restructuring, and major goodwill impairment.MODV
Q2 202529 Dec 2025 - Chapter 11 restructuring confirmed; revenue and membership down, equity to be canceled.MODV
Q3 202529 Dec 2025 - Healthcare services firm files $200M shelf for flexible equity, debt, and warrant offerings.MODV
Registration Filing16 Dec 2025 - Revenue up 1.3% to $2.79B, but losses and margin pressures persist amid industry disruption.MODV
Q4 202412 Dec 2025 - $105M in new financing, board changes, and a strategic review aim to stabilize operations.MODV
Proxy Filing1 Dec 2025 - Director elections, executive pay, and auditor ratification headline the 2025 annual meeting.MODV
Proxy Filing1 Dec 2025 - Stockholders to vote on $30M note issuance and $20.165M exchange to bolster financial position.MODV
Proxy Filing1 Dec 2025